Biomarkers of liver fibrosis

QR Code

Biomarkers of liver fibrosis

Currently the only accepted method (gold standard) for the diagnosis of the fibrotic stages of chronic liver disease (CLD) is liver biopsy, to allow histological assessment. Liver biopsy is an invasive investigation associated with a range adverse events (e.g. pain, haemorrhage) limiting its serial...

Full description

Bibliographic Details
Main Authors:	Morling, Joanne R., Guha, Indra Neil
Format:	Article
Published:	Wiley 2016
Online Access:	https://eprints.nottingham.ac.uk/34456/

Similar Items

Prevalence of clinically significant liver disease within the general population, as defined by non-invasive markers of liver fibrosis: a systematic review
by: Harris, Rebecca, et al.
Published: (2017)

Using non-invasive biomarkers to identify hepatic fibrosis in people with type 2 diabetes mellitus: the Edinburgh type 2 diabetes study
by: Morling, Joanne R., et al.
Published: (2014)

Biomarkers of progressive lung fibrosis
by: Khan, Fasihul
Published: (2022)

γ-Glutamyltransferase, but not markers of hepatic fibrosis, is associated with cardiovascular disease in older people with type 2 diabetes mellitus: the Edinburgh Type 2 Diabetes Study
by: Morling, Joanne R., et al.
Published: (2015)

Clinically significant chronic liver disease in people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study
by: Morling, Joanne R., et al.
Published: (2016)

Texture-based classification of liver fibrosis using MRI
by: House, M., et al.
Published: (2015)

SOX9 predicts progression towards cirrhosis in patients while its loss protects against liver fibrosis
by: Athwal, Varinder S., et al.
Published: (2017)

Biomarkers of drug-induced liver injury
by: Atallah, Edmond
Published: (2024)

Biomarkers to predict advanced liver diseases
by: Alenezi, Yusef
Published: (2024)

Analysis of genotyping for predicting liver injury marker, Procollagen III in persons at risk of non-alcoholic fatty liver disease
by: Grove, Jane I., et al.
Published: (2018)

An epithelial biomarker signature for idiopathic pulmonary fibrosis: an analysis from the multicentre PROFILE cohort study
by: Maher, Toby M., et al.
Published: (2017)

Interferon-[gamma] exacerbates liver damage, the hepatic progenitor cell response and fibrosis in a mouse model of chronic liver injury
by: Knight, B., et al.
Published: (2007)

Hepatic elastin content is predictive of adverse outcome in advanced fibrotic liver disease
by: Kendall, Timothy, et al.
Published: (2018)

Bile acids associate with specific gut microbiota, low-level alcohol consumption and liver fibrosis in patients with non-alcoholic fatty liver disease
by: Adams, L.A., et al.
Published: (2020)

MBOAT7 rs641738 increases risk of liver inflammation and transition to fibrosis in chronic hepatitis C
by: Thabet, Khaled, et al.
Published: (2016)

Taurocholate Induces Biliary Differentiation of Liver Progenitor Cells Causing Hepatic Stellate Cell Chemotaxis in the Ductular Reaction: Role in Pediatric Cystic Fibrosis Liver Disease
by: Pozniak, K., et al.
Published: (2017)

Longitudinal change in collagen degradation biomarkers in idiopathic pulmonary fibrosis: an analysis from the prospective, multicentre PROFILE study
by: Jenkins, R. Gisli, et al.
Published: (2015)

Association between psychological distress and liver disease mortality: a meta-analysis of individual study participants
by: Russ, Tom C., et al.
Published: (2015)

Isoaspartate, Carbamoyl phosphate synthase-1, and carbonic anhydrase-III as biomarkers of liver injury
by: Carter, Wayne, et al.
Published: (2016)

Entamoeba histolytica acetyl-CoA synthetase: biomarker of acute amoebic liver abscess
by: Lim, Boon Huat, et al.
Published: (2014)

Molecular biomarkers and genetic determinants of non-alcoholic fatty liver disease / Tan Hwa Li
by: Tan, Hwa Li
Published: (2019)

Economic evaluation of a community-based diagnostic pathway to stratify adults for non-alcoholic fatty liver disease: a Markov model informed by a feasibility study
by: Tanajewski, Lukasz, et al.
Published: (2017)

ADAPT: an algorithm incorporating PRO-C3 accurately identifies patients with NAFLD and advanced fibrosis
by: Daniels, Samuel J., et al.
Published: (2018)

ADAPT: an algorithm incorporating PRO-C3 accurately identifies patients with NAFLD and advanced fibrosis
by: Daniels, Samuel J., et al.
Published: (2018)

Direct targeting of risk factors significantly increases the detection of liver cirrhosis in primary care: a cross-sectional diagnostic study utilising transient elastography
by: Harman, David J., et al.
Published: (2015)

US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis
by: Floto, R. Andres, et al.
Published: (2016)

let-7g-5p suppresses the proliferation and expansion of hepatic stellate cells in liver fibrosis via targeting FGF5
by: Zhou, Jiaming, et al.
Published: (2025)

Identification of some novel biomarkers for assessment of copper sulphate toxicity in liver of Puntius javanicus through proteomic analyses
by: Sabullah, Mohd Khalizan, et al.
Published: (2020)

Effectiveness of luseogliflozin over conventional therapy on liver fibrosis, disease activity and metabolic attributes in patients with metabolic associated fatty liver disease and type ii diabetes mellitus: an open-label randomized controlled trial
by: Mazri, Mohamad Syamil
Published: (2023)

Airway infection and Pseudomonas aeruginosa in bronchiectasis (cystic fibrosis and non-cystic fibrosis bronchiectasis)
by: Webb, Karmel
Published: (2022)

Understanding chronic inflammatory diseases in the human lung: the cystic fibrosis and idiopathic pulmonary fibrosis paradigms
by: Liu, Yi-Chia
Published: (2014)

Cystic fibrosis microbiology: advances in antimicrobial therapy
by: Waters, Valerie, et al.
Published: (2015)

Prophylactic anti-staphylococcal antibiotics for cystic fibrosis
by: Smyth, Alan R., et al.
Published: (2014)

Delayed publications of clinical trials in cystic fibrosis
by: Hurley, M.N., et al.
Published: (2011)

Refining in-vivo models of pulmonary fibrosis
by: Habgood, Anthony
Published: (2018)

Perceptions of Population Cystic Fibrosis Prenatal and Preconception Carrier Screening Among Individuals with Cystic Fibrosis and Their Family Members
by: Maxwell, Susannah, et al.
Published: (2011)

Cardiac fibrosis in the ageing heart: Contributors and mechanisms
by: Lu, L., et al.
Published: (2017)

Completeness of primary intracranial tumour recording in the Scottish Cancer Registry 2011-12
by: Morling, Joanne R., et al.
Published: (2016)

POLYMICROBIAL INFECTION AND NEUTROPHILIC DISEASE IN CYSTIC FIBROSIS AIRWAYS
by: Laucirica, D.R., et al.
Published: (2019)

Multiple-breath washout as a lung function test in cystic fibrosis: A cystic fibrosis foundation workshop report
by: Subbarao, P., et al.
Published: (2015)